Not only inhibits tumor growth by enhancing phagocytosis to tumor cells, but RHO-associated kinase (ROCK) block also initiates T cells and anti-tumor immunity, where the proportion of CD8+ T cells increases significantly 48. Here, CD8A is linked to neoplasm.